621 related articles for article (PubMed ID: 23777684)
1. Systematic documentation of new vaccine introduction in selected countries of the Latin American Region.
de Oliveira LH; Toscano CM; Sanwogou NJ; Ruiz-Matus C; Tambini G; Roses-Periago M; Andrus JK
Vaccine; 2013 Jul; 31 Suppl 3():C114-22. PubMed ID: 23777684
[TBL] [Abstract][Full Text] [Related]
2. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
[TBL] [Abstract][Full Text] [Related]
3. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination.
Clark A; Jauregui B; Griffiths U; Janusz CB; Bolaños-Sierra B; Hajjeh R; Andrus JK; Sanderson C
Vaccine; 2013 Jul; 31 Suppl 3():C19-29. PubMed ID: 23777686
[TBL] [Abstract][Full Text] [Related]
4. Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: the ProVac experience.
Toscano CM; Jauregui B; Janusz CB; Sinha A; Clark AD; Sanderson C; Resch S; Ruiz Matus C; Andrus JK;
Vaccine; 2013 Jul; 31 Suppl 3():C12-8. PubMed ID: 23777685
[TBL] [Abstract][Full Text] [Related]
5. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
6. Progress in the introduction of rotavirus vaccine--Latin America and the Caribbean, 2006-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(47):1611-4. PubMed ID: 22129995
[TBL] [Abstract][Full Text] [Related]
7. ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions.
Jauregui B; Janusz CB; Clark AD; Sinha A; Garcia AG; Resch S; Toscano CM; Sanderson C; Andrus JK
Vaccine; 2015 May; 33 Suppl 1():A21-7. PubMed ID: 25919164
[TBL] [Abstract][Full Text] [Related]
8. Evidence base for vaccine introduction in Latin America and the Caribbean. Foreword.
Etienne CF
Vaccine; 2013 Jul; 31 Suppl 3():C1. PubMed ID: 23777681
[No Abstract] [Full Text] [Related]
9. Declines in Pneumonia Mortality Following the Introduction of Pneumococcal Conjugate Vaccines in Latin American and Caribbean Countries.
de Oliveira LH; Shioda K; Valenzuela MT; Janusz CB; Rearte A; Sbarra AN; Warren JL; Toscano CM; Weinberger DM;
Clin Infect Dis; 2021 Jul; 73(2):306-313. PubMed ID: 32448889
[TBL] [Abstract][Full Text] [Related]
10. Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned.
de Oliveira LH; Trumbo SP; Ruiz Matus C; Sanwogou NJ; Toscano CM
Expert Rev Vaccines; 2016 Oct; 15(10):1295-304. PubMed ID: 26982434
[TBL] [Abstract][Full Text] [Related]
11. Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines.
De la Hoz-Restrepo F; Castañeda-Orjuela C; Paternina A; Alvis-Guzman N
Vaccine; 2013 Jul; 31 Suppl 3():C80-7. PubMed ID: 23777697
[TBL] [Abstract][Full Text] [Related]
12. New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries.
Burchett HE; Mounier-Jack S; Griffiths UK; Biellik R; Ongolo-Zogo P; Chavez E; Sarma H; Uddin J; Konate M; Kitaw Y; Molla M; Wakasiaka S; Gilson L; Mills A
Health Policy Plan; 2012 May; 27 Suppl 2():ii5-16. PubMed ID: 22513732
[TBL] [Abstract][Full Text] [Related]
13. Population access to new vaccines in European countries.
Blank PR; Schwenkglenks M; Sardos CS; Patris J; Szucs TD
Vaccine; 2013 Jun; 31(27):2862-7. PubMed ID: 23632307
[TBL] [Abstract][Full Text] [Related]
14. Rotavirus vaccine introduction in the Americas: progress and lessons learned.
de Oliveira LH; Danovaro-Holliday MC; Matus CR; Andrus JK
Expert Rev Vaccines; 2008 Apr; 7(3):345-53. PubMed ID: 18393604
[TBL] [Abstract][Full Text] [Related]
15. Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review.
Saokaew S; Rayanakorn A; Wu DB; Chaiyakunapruk N
Pharmacoeconomics; 2016 Dec; 34(12):1211-1225. PubMed ID: 27510721
[TBL] [Abstract][Full Text] [Related]
16. Andean region: measles on the way out.
EPI Newsl; 1996 Oct; 18(5):1-3. PubMed ID: 12320547
[TBL] [Abstract][Full Text] [Related]
17. Performing Country-led Economic Evaluations to Inform Immunization Policy: ProVac Experiences in Latin America and the Caribbean.
Janusz CB; Jauregui B; Sinha A; Clark AD; Bolaños BM; Resch S; Toscano C; Andrus JK
Value Health Reg Issues; 2012 Dec; 1(2):248-253. PubMed ID: 29702908
[TBL] [Abstract][Full Text] [Related]
18. What criteria do decision makers in Thailand use to set priorities for vaccine introduction?
Pooripussarakul S; Riewpaiboon A; Bishai D; Muangchana C; Tantivess S
BMC Public Health; 2016 Aug; 16():684. PubMed ID: 27484123
[TBL] [Abstract][Full Text] [Related]
19. Introduction of new vaccines: decision-making process in Bangladesh.
Uddin J; Sarma H; Bari TI; Koehlmoos TP
J Health Popul Nutr; 2013 Jun; 31(2):211-7. PubMed ID: 23930339
[TBL] [Abstract][Full Text] [Related]
20. Rotavirus vaccination in Central American children.
Ulloa-Gutierrez R; Avila-Aguero ML
Expert Rev Vaccines; 2014 Jun; 13(6):687-90. PubMed ID: 24702467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
